Cargando…
Onset dynamics of type A botulinum neurotoxin-induced paralysis
Experimental studies have demonstrated that botulinum neurotoxin serotype A (BoNT/A) causes flaccid paralysis by a multi-step mechanism. Following its binding to specific receptors at peripheral cholinergic nerve endings, BoNT/A is internalized by receptor-mediated endocytosis. Subsequently its zinc...
Autores principales: | Lebeda, Frank J., Adler, Michael, Erickson, Keith, Chushak, Yaroslav |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2798021/ https://www.ncbi.nlm.nih.gov/pubmed/18551355 http://dx.doi.org/10.1007/s10928-008-9087-3 |
Ejemplares similares
-
The Zinc-Dependent Protease Activity of the Botulinum Neurotoxins
por: Lebeda, Frank J., et al.
Publicado: (2010) -
Preclinical Evidence for the Role of Botulinum Neurotoxin A (BoNT/A) in the Treatment of Peripheral Nerve Injury
por: Adler, Michael, et al.
Publicado: (2022) -
Botulinum Neurotoxins Serotypes A and B induce paralysis of mouse striated and smooth muscles with different potencies
por: Maignel‐Ludop, Jacquie, et al.
Publicado: (2017) -
Revealing the Therapeutic Potential of Botulinum Neurotoxin Type A in Counteracting Paralysis and Neuropathic Pain in Spinally Injured Mice
por: Vacca, Valentina, et al.
Publicado: (2020) -
Kinetic and Reaction Pathway Analysis in the Application of Botulinum Toxin A for Wound Healing
por: Lebeda, Frank J., et al.
Publicado: (2012)